{
    "clinical_study": {
        "@rank": "157938", 
        "arm_group": [
            {
                "arm_group_label": "oral quercetin capsules", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in the intervention group were administered two, 250 mg Quercetin capsules daily for 3 weeks"
            }, 
            {
                "arm_group_label": "oral placebo capsules", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients in the placebo group received two placebo capsules containing lactose ."
            }
        ], 
        "brief_summary": {
            "textblock": "The study aims to evaluate the effect of Quercetin (a natural flavonoid) on prevention of\n      and treatment of chemotherapy-induced oral mucositis in patients with blood malignancies."
        }, 
        "brief_title": "Effect of Quercetin in Prevention and Treatment of Oral Mucositis", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": "Chemotherapy Induced Oral Mucositis", 
        "condition_browse": {
            "mesh_term": [
                "Stomatitis", 
                "Mucositis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient under chemotherapy\n\n          -  for  a hematologic malignancy\n\n          -  the hematologist permits the trial on the patient\n\n          -  agreement of patient for participating in the trial\n\n        Exclusion Criteria:\n\n          -  presence pf ANY oral lesion at the beginning of the trial\n\n          -  loss of follow up\n\n          -  use of digoxin and cyclosporine\n\n          -  patient death"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732393", 
            "org_study_id": "89470"
        }, 
        "intervention": [
            {
                "arm_group_label": "oral quercetin capsules", 
                "description": "10 cases in case group and 10 cases in control group. Patients in the intervention group were administered two, 250 mg Quercetin capsules daily for 3 weeks. Patients in the placebo group received two placebo capsules containing lactose .Patients  were examined every other day for evaluation of  initiation and severity of oral mucositis.", 
                "intervention_name": "oral quercetin capsules", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "oral placebo capsules", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Quercetin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Quercetin", 
            "Chemotherapy", 
            "Mucositis", 
            "Hematologic  Malignancies"
        ], 
        "lastchanged_date": "December 4, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "MAshhad", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Khorasan Razavi", 
                    "zip": "91735-498"
                }, 
                "name": "Oral Medicine Department of Mashhad dental School"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias", 
        "overall_official": {
            "affiliation": "Mashhad University of Medical Sciences", 
            "last_name": "Pegah Mosannen Mozafari, assistant professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "October 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "grade of mucositis due to WHO criteria", 
            "measure": "lower grade of mucositis", 
            "safety_issue": "No", 
            "time_frame": "3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732393"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mashhad University of Medical Sciences", 
            "investigator_full_name": "Pegah Mosannen Mozafari", 
            "investigator_title": "assistant professor of oral medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "duration of mucositis due to Who criteria", 
            "measure": "duration of mucositis", 
            "safety_issue": "No", 
            "time_frame": "3 weeks of study tiem span and after trial"
        }, 
        "source": "Mashhad University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mashhad University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}